Domov › Vnetna črevesna bolezen › Texas

Klinične študije za Vnetna črevesna bolezen v Texas

16 študij za Vnetna črevesna bolezen išče udeležence na lokacijah v Texas.

Mesta v Texas

Uradno besedilo študije (angleško)

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Inquest Clinical Research, Baytown
DHR Health Gastroenterology - Edinburg, Edinburg
Baylor College of Medicine, Houston
in še 3

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Xencor Investigative Site, Cedar Park
Xencor Investigative Site, Denton
Xencor Investigative Site, Garland
in še 8

Vključevanje udeležencevFaza 1/2Vabljeni zdravi prostovoljci

Starost 18–75 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Site 013, Cedar Park
Site 005, Garland
Site 002, San Antonio
in še 2

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Site US-024, Garland
Site US-009, Georgetown
Site US-030, Houston
in še 4

Vključevanje udeležencevFaza 2

Starost 18–75 · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT07845487

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Cook Childrens Medical Center, Fort Worth

Vključevanje udeležencevFaza 3

Starost 2–17 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05923073

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

UT Southwestern Simmons Cancer Center - RedBird, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
in še 2

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT03816345

Study of DISC-0974-201 in Participants With IBD and Anemia

One of a Kind Clinical Research Center, LLC, Kingwood
Siena Research Network, Sugar Land

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07368972

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

GI Alliance - Cedar Park, Cedar Park
North Texas Gastroenterology, Denton
The University of Texas Health Science Center at Houston, Houston
in še 3

Vključevanje udeležencevFaza 2

Starost 18–85 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06226883

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Cook Children's Medical Center, Fort Worth

Vključevanje udeležencevFaza 3

Starost 2–19 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT04844606

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

Cook Children's Medical Center, Fort Worth

Vključevanje udeležencevFaza 3

Starost 2–17 · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT05509777

BOOM-IBD2 Pivotal Clinical Trial

Amarillo Premier Research (Objective Health), Amarillo
Digestive Research of Central Texas (Objective Health), Waco

Vključevanje udeležencev

Starost 18–85 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06571669

HB-adMSCs for the Treatment of Crohn's Disease

Hope Biosciences Research Foundation, Sugar Land

Vključevanje udeležencevFaza 2

Starost 18–65 · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT07077746

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M D Anderson Cancer Center, Houston

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 20. maj 2026 · NCT04751396

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Mirador Therapeutics Selected Site, Dallas
Mirador Therapeutics Selected Site, Garland
Mirador Therapeutics Selected Site, Georgetown
in še 5

Vključevanje udeležencevFaza 2

Starost 18–80 · Vsi spoli · Posodobljeno 12. mar. 2026 · NCT07113522

Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 11. mar. 2026 · NCT07210580

Registry and Biorepository for IBD in Central Texas

Dell Medical School, UT Austin, Austin

Vključevanje udeležencevOpazovalna študija

Starost 18–100 · Vsi spoli · Posodobljeno 18. maj 2021 · NCT04617184

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.